Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Alnylam reaches alignment with FDA on safety measures for fitusiran program

Nov. 10, 2017

Memantine improves red blood cell parameters, quality of life in sickle cell patients

Nov. 8, 2017

FDA gives fast track designation to imetelstat for lower risk MDS

Nov. 2, 2017

New lower dose of rivaroxaban approved by FDA

Oct. 31, 2017

European Commission approves new indication for Firazyr

Oct. 27, 2017

FDA gives breakthrough therapy designation to valoctocogene roxaparvovec

Oct. 27, 2017

Ergomed reports phase II topline results for first-in-class hemostat PeproStat

Oct. 23, 2017

Health Canada gives priority review status to ProMetic's NDS for Ryplazim

Oct. 20, 2017

Acticor Biotech reaches agreement on phase I study of ACT-107

Oct. 18, 2017

Bayer submits marketing authorization application for BAY-94-9027 in Japan

Oct. 18, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...